Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor checkpoint

Alexander P Miceli1, Anthony J Saporita, Jason D Weber

  • 1BRIGHT Institute, Department of Internal Medicine, Division of Molecular Oncology, and Department of Cell Biology and Physiology, Siteman Cancer Center, Washington University School of Medicine, Saint Louis, Missouri, USA.

Insights

The ARF tumor suppressor protein prevents cancer by sensing hypergrowth signals. New research shows Ras/TSC/mTORC1 signaling enhances ARF protein production via translation, not just transcription, to halt tumor formation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The ARF tumor suppressor monitors hyperproliferative signals from oncogenic pathways.
  • Oncogenic Ras(V12) signaling typically induces ARF via the Dmp1 transcription factor.
  • A gap exists in understanding ARF regulation beyond Dmp1-mediated transcriptional control.

Purpose of the Study:

  • To investigate the role of the Ras/TSC/mTORC1 pathway in ARF regulation.
  • To elucidate the translational mechanisms controlling ARF protein expression in response to oncogenic signaling.
  • To confirm ARF's tumor-suppressive function independent of Dmp1.

Main Methods:

  • Utilized cell culture models with genetic manipulations (e.g., Tsc1 loss, Arf deletion).
  • Employed techniques to assess protein expression, mRNA translation, cell cycle progression, and p53 pathway activation.
  • Evaluated tumor formation using soft agar assays and an allograft tumor burden model.

Main Results:

  • Ras(V12) induces ARF protein expression through enhanced translation of Arf mRNA, even without Dmp1.
  • Hyperactivation of mTORC1 (via Tsc1 loss) significantly increases ARF expression and p53 pathway activation, causing cell cycle arrest.
  • ARF protein, induced translationally, effectively suppresses anchorage-independent growth and tumor burden.

Conclusions:

  • The Ras/TSC/mTORC1 pathway regulates ARF protein expression via a novel translational mechanism.
  • ARF acts as a critical tumor suppressor by responding to hypergrowth signals through translational control.
  • This pathway provides a new target for cancer therapies aimed at restoring ARF-mediated tumor suppression.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...